EyePoint Pharmaceuticals, Inc. Interest Expense in USD from 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2016 to Q2 2024.
  • EyePoint Pharmaceuticals, Inc. Interest Expense for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • EyePoint Pharmaceuticals, Inc. Interest Expense for the twelve months ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Interest Expense for 2023 was $1.25M, a 60.9% decline from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Interest Expense for 2022 was $3.19M, a 42% decline from 2021.
  • EyePoint Pharmaceuticals, Inc. annual Interest Expense for 2021 was $5.5M, a 24.2% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)

EyePoint Pharmaceuticals, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $0 $0 -$435K -100% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $435K $0 -$812K -100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.25M $0 -$781K -100% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 $2.03M $0 -$662K -100% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $2.69M $435K -$117K -21.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $2.81M $812K -$382K -32% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $3.19M $781K -$607K -43.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 $3.8M $662K -$726K -52.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $4.52M $552K -$824K -59.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $5.35M $1.19M -$152K -11.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $5.5M $1.39M -$439K -24% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 $5.94M $1.39M -$452K -24.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $6.39M $1.38M -$430K -23.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $6.82M $1.35M -$438K -24.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $7.26M $1.83M +$40K +2.24% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $7.22M $1.84M +$70K +3.96% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $7.15M $1.81M +$207K +12.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $6.94M $1.78M +$764K +74.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $6.18M $1.79M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 $1.77M +$955K +117% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $1.6M +$879K +122% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $1.02M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q3 2018 $815K +$815K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $720K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q3 2017 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09

EyePoint Pharmaceuticals, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.25M -$1.94M -60.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 $3.19M -$2.31M -42% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 $5.5M -$1.76M -24.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 $7.26M +$1.08M +17.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $6.18M +$3.81M +161% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $2.36M +$2.36M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $0 $0 Jul 1, 2016 Jun 30, 2017 10-KT 2019-03-18
2016 $0 Jul 1, 2015 Jun 30, 2016 10-KT 2019-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.